128 related articles for article (PubMed ID: 16821788)
1. Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis.
Biegel A; Gebauer S; Brandsch M; Neubert K; Thondorf I
J Med Chem; 2006 Jul; 49(14):4286-96. PubMed ID: 16821788
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Biegel A; Gebauer S; Hartrodt B; Brandsch M; Neubert K; Thondorf I
J Med Chem; 2005 Jun; 48(13):4410-9. PubMed ID: 15974593
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
Gebauer S; Knütter I; Hartrodt B; Brandsch M; Neubert K; Thondorf I
J Med Chem; 2003 Dec; 46(26):5725-34. PubMed ID: 14667225
[TBL] [Abstract][Full Text] [Related]
4. The renal type H+/peptide symporter PEPT2: structure-affinity relationships.
Biegel A; Knütter I; Hartrodt B; Gebauer S; Theis S; Luckner P; Kottra G; Rastetter M; Zebisch K; Thondorf I; Daniel H; Neubert K; Brandsch M
Amino Acids; 2006 Sep; 31(2):137-56. PubMed ID: 16868651
[TBL] [Abstract][Full Text] [Related]
5. Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Luckner P; Brandsch M
Eur J Pharm Biopharm; 2005 Jan; 59(1):17-24. PubMed ID: 15567297
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).
Thondorf I; Voigt V; Schäfer S; Gebauer S; Zebisch K; Laug L; Brandsch M
Bioorg Med Chem; 2011 Nov; 19(21):6409-18. PubMed ID: 21955456
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
8. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
[TBL] [Abstract][Full Text] [Related]
9. Comparative molecular field analysis and comparative molecular similarity indices analysis of boron-containing human thymidine kinase 1 substrates.
Bandyopadhyaya AK; Tiwari R; Tjarks W
Bioorg Med Chem; 2006 Oct; 14(20):6924-32. PubMed ID: 16828556
[TBL] [Abstract][Full Text] [Related]
10. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
Zhou YJ; Zhu LP; Tang Y; Ye DY
Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624
[TBL] [Abstract][Full Text] [Related]
11. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Yi P; Fang X; Qiu M
Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
[TBL] [Abstract][Full Text] [Related]
14. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
15. Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.
Fei YJ; Liu JC; Fujita T; Liang R; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(1):39-44. PubMed ID: 9600064
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
17. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
18. Recognition of 2-aminothiazole-4-acetic acid derivatives by the peptide transporters PEPT1 and PEPT2.
Biegel A; Gebauer S; Hartrodt B; Knütter I; Neubert K; Brandsch M; Thondorf I
Eur J Pharm Sci; 2007 Sep; 32(1):69-76. PubMed ID: 17644326
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors.
Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK
J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201
[TBL] [Abstract][Full Text] [Related]
20. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]